Contact Person : Bill Nothofer; Last Date for the submission of abstract : Not Available ; Description : The major world-wide push to fund more research, vaccine development, and clinical capacity for addressing infectious diseases and pathogens is driving a new round of cost-effective solutions for BSL-rated facilities.